Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreMaking Sense of Robotic Surgery
Read moreTreating heart failure through innovative RNA-therapies
Read moreYour expenses and company credit cards on autopilot
Read moreAgile space technology to connect the world
Read moreSmart Data Capture
Read moreOnline tools to edit PDFs
Read moreCapturing CO2 from air
Read more